The Erbb3-Targeting Antibody Mm-121 (Seribantumab) Reverses Heregulin-Driven Resistance To Multiple Chemotherapies On Tumor Cell Growth
CANCER RESEARCH(2015)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined